Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

164 ta ish

Ish: Invisible influencers: the tumor microbiome’s impact on immunotherapy in colorectal cancer (CRC)

  1. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67

    Maqola20176 iqtibos
    ABI

  2. Regulatory mechanisms of PD-1/PD-L1 in cancers

    Xin Lin, Kuan Kang, Pan Chen +5

    Maqola20245 iqtibos
    ABI

  3. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

    Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa +45

    Maqola20175 iqtibos
    ABI

  4. Symbiotic Bacterial Metabolites Regulate Gastrointestinal Barrier Function via the Xenobiotic Sensor PXR and Toll-like Receptor 4

    Madhukumar Venkatesh, Subhajit Mukherjee, Hongwei Wang +16

    Maqola20143 iqtibos
    ABI

  5. Innate and adaptive immune cells in the tumor microenvironment

    Thomas F. Gajewski, Hans Schreiber, Yang‐Xin Fu

    Sharh maqola20133 iqtibos
    ABI

  6. A human gut microbial gene catalogue established by metagenomic sequencing

    Junjie Qin, Ruiqiang Li, Jeroen Raes +50

    Maqola20103 iqtibos
    ABI

  7. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

    Marie Vétizou, Jonathan M. Pitt, Romain Daillère +35

    Maqola20153 iqtibos
    ABI

  8. The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients

    Vyara Matson, Jessica Fessler, Riyue Bao +5

    Maqola20183 iqtibos
    ABI

  9. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

    Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel +29

    Maqola20203 iqtibos
    ABI

  10. Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

    Diwakar Davar, Amiran Dzutsev, John A. McCulloch +29

    Maqola20213 iqtibos
    ABI

  11. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity

    Takeshi Tanoue, Satoru Morita, Damian R. Plichta +25

    Maqola20192 iqtibos
    ABI

  12. Drug-Resistant <i>E. coli</i> Bacteremia Transmitted by Fecal Microbiota Transplant

    Zachariah DeFilipp, Patricia P. Bloom, Mariam Torres Soto +7

    Maqola20192 iqtibos
    ABI

  13. Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?

    S Deleu, Kathleen Machiels, Jeroen Raes +2

    Sharh maqola20212 iqtibos
    ABI

  14. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites

    Ara Koh, Filipe De Vadder, Petia Kovatcheva‐Datchary +1

    Sharh maqola20162 iqtibos
    ABI

  15. Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma

    Melissa Borgia, Michele Dal Bo, Giuseppe Toffoli

    Sharh maqola20212 iqtibos
    ABI

  16. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites

    William R. Wikoff, Andrew Anfora, Jun Liu +4

    Maqola20092 iqtibos
    ABI

  17. Microbiota: a key orchestrator of cancer therapy

    Soumen Roy, Giorgio Trinchieri

    Sharh maqola20172 iqtibos
    ABI

  18. Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer

    Susan Bullman, Chandra Sekhar Pedamallu, Ewa Sicińska +26

    Maqola20172 iqtibos
    ABI

  19. Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment

    Mackenzie Bender, Alex McPherson, Catherine M. Phelps +22

    Maqola20232 iqtibos
    ABI

  20. <i>Roseburia intestinalis</i> generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8 <sup>+</sup> T cells

    Xing Kang, Changan Liu, Yanqiang Ding +7

    Maqola20232 iqtibos
    ABI

  21. Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer

    Pasquale Marino, Mariangela Mininni, Giovanni Deiana +7

    Maqola20242 iqtibos
    ABI

  22. The role of polyamine metabolism in remodeling immune responses and blocking therapy within the tumor immune microenvironment

    Jiachun Lian, Yanfang Liang, Hailiang Zhang +5

    Sharh maqola20222 iqtibos
    ABI

  23. Nanoparticle biointerfacing by platelet membrane cloaking

    Che‐Ming Jack Hu, Ronnie H. Fang, Kuei-Chun Wang +19

    Maqola20152 iqtibos
    ABI

  24. Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation

    Marta Wlodarska, Chengwei Luo, Raivo Kolde +19

    Maqola20172 iqtibos
    ABI

  25. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota

    Danfeng Chen, Duochen Jin, Shumin Huang +12

    Maqola20192 iqtibos
    ABI